Barclays assumed coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA) in a research note released on Thursday, Marketbeat Ratings reports. The brokerage issued an equal weight rating and a $76.00 target price on the pharmacy operator’s stock.
A number of other brokerages have also recently weighed in on WBA. Zacks Investment Research cut Walgreens Boots Alliance from a buy rating to a hold rating in a research note on Monday, January 22nd. Mizuho set a $87.00 price objective on Walgreens Boots Alliance and gave the company a buy rating in a research note on Wednesday, January 24th. ValuEngine cut Walgreens Boots Alliance from a buy rating to a hold rating in a research note on Friday, February 2nd. Evercore ISI began coverage on Walgreens Boots Alliance in a research note on Thursday, January 4th. They issued an outperform rating and a $80.00 price objective for the company. Finally, Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the company a buy rating in a research note on Wednesday, January 3rd. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of Buy and a consensus target price of $84.75.
Walgreens Boots Alliance (WBA) opened at $70.60 on Thursday. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $69,940.00, a P/E ratio of 19.50, a P/E/G ratio of 1.16 and a beta of 1.21. Walgreens Boots Alliance has a fifty-two week low of $63.82 and a fifty-two week high of $87.79.
The business also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.27%. The ex-dividend date is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 44.20%.
In related news, insider Stefano Pessina purchased 98,858 shares of the business’s stock in a transaction dated Monday, January 15th. The stock was acquired at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 14.80% of the stock is owned by corporate insiders.
Several institutional investors have recently added to or reduced their stakes in the company. Pathstone Family Office LLC raised its position in Walgreens Boots Alliance by 226.6% in the second quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock worth $1,969,000 after acquiring an additional 818 shares in the last quarter. Westside Investment Management Inc. raised its position in Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 125 shares in the last quarter. Zions Bancorporation raised its position in Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,239 shares in the last quarter. Bristlecone Advisors LLC purchased a new position in Walgreens Boots Alliance in the third quarter worth $135,000. Finally, Financial Advocates Investment Management purchased a new position in Walgreens Boots Alliance in the fourth quarter worth $125,000. Institutional investors and hedge funds own 60.12% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.